SCHEMBL24676774

SCHEMBL24676774

COc1nc(C)c(-c2nc(NC3CCN(S(C)(=O)=O)CC3)ncc2F)s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 20/20 0.59
CDK1 P06493 12/20 0.59
CCNE1 P24864 11/20 0.59
CCNE2 O96020 5/20 0.59
CDK5 Q00535 4/20 0.59
CCNB1 P14635 4/20 0.59
CCNB2 O95067 3/20 0.59
CDK5R1 Q15078 3/20 0.59
CCNB3 Q8WWL7 3/20 0.59
CDK4 P11802 10/20 0.53
CCND1 P24385 10/20 0.53
CDK6 Q00534 3/20 0.53
CCND3 P30281 2/20 0.53
CCNA2 P20248 1/20 0.53
CASK O14936 1/20 0.47
ROCK2 O75116 1/20 0.47
CDKL5 O76039 1/20 0.47
STK10 O94804 1/20 0.47
CDK14 O94921 1/20 0.47
ABL1 P00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24676659 0.90 CDK2 (0.56) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL24676656 0.90 CDK2 (0.56) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL25402367 0.88 CDK2 (0.63) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL30537172 0.88 CDK2 (0.63) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL24675986 0.87 CDK2 (0.66) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL24676776 0.87 CDK2 (0.61) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL24676710 0.86 CDK2 (0.56) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL24675966 0.86 CDK2 (0.60) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL24676711 0.86 CDK2 (0.60) CDK2CDK1CCNE1CCNE2CDK5
SCHEMBL24676736 0.86 CDK2 (0.60) CDK2CDK1CCNE1CCNE2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed